IL-9 and IL-9-producing cells in tumor immunity

[1]  N. Krogan,et al.  Mapping genetic interactions in cancer: a road to rational combination therapies , 2019, Genome Medicine.

[2]  L. Tang,et al.  T Helper 9 Cells: A New Player in Immune-Related Diseases , 2019, DNA and cell biology.

[3]  Jun Zhang,et al.  IL-9-producing CD8+ T cells represent a distinctive subset with different transcriptional characteristics from conventional CD8+ T cells, and partially infiltrate breast tumors. , 2019, The international journal of biochemistry & cell biology.

[4]  C. Taube,et al.  Mast cells drive IgE-mediated disease but may be bystanders in many other inflammatory and neoplastic conditions. , 2019, The Journal of allergy and clinical immunology.

[5]  D. Conrad,et al.  The Il9 CNS-25 Regulatory Element Controls Mast Cell and Basophil IL-9 Production , 2019, The Journal of Immunology.

[6]  Xu Li,et al.  Fas signaling-mediated TH9 cell differentiation favors bowel inflammation and antitumor functions , 2019, Nature Communications.

[7]  G. Jin,et al.  IL-4 together with IL-1β induces antitumor Th9 cell differentiation in the absence of TGF-β signaling , 2019, Nature Communications.

[8]  P. Angkasekwinai.  Th9 Cells in Allergic Disease , 2019, Current Allergy and Asthma Reports.

[9]  Yue Zhang,et al.  Effect of Th9/IL-9 on the growth of gastric cancer in nude mice , 2019, OncoTargets and therapy.

[10]  Yuan Zhang,et al.  Human TH9 differentiation is dependent on signal transducer and activator of transcription (STAT) 3 to restrain STAT1‐mediated inhibition , 2019, The Journal of allergy and clinical immunology.

[11]  F. Cunha,et al.  B lymphocyte–induced maturation protein 1 controls TH9 cell development, IL‐9 production, and allergic inflammation , 2019, The Journal of allergy and clinical immunology.

[12]  Y. Zhuang,et al.  Increased intratumoral mast cells foster immune suppression and gastric cancer progression through TNF-α-PD-L1 pathway , 2019, Journal of Immunotherapy for Cancer.

[13]  Yeonseok Chung,et al.  GM-CSF Promotes Antitumor Immunity by Inducing Th9 Cell Responses , 2019, Cancer Immunology Research.

[14]  Siqing Wang,et al.  TNF-α enhances Th9 cell differentiation and antitumor immunity via TNFR2-dependent pathways , 2019, Journal of Immunotherapy for Cancer.

[15]  J. O’Shea,et al.  Retinoic Acid Receptor Alpha Represses a Th9 Transcriptional and Epigenomic Program to Reduce Allergic Pathology , 2019, Immunity.

[16]  S. Janga,et al.  A conserved enhancer regulates Il9 expression in multiple lineages , 2018, Nature Communications.

[17]  P. Zhang,et al.  Lentiviral vector-mediated IL-9 overexpression stimulates cell proliferation by targeting c-myc and cyclin D1 in colitis-associated cancer , 2018, Oncology letters.

[18]  Maojie Yang,et al.  Cholesterol negatively regulates IL-9–producing CD8+ T cell differentiation and antitumor activity , 2018, The Journal of experimental medicine.

[19]  C. Dong,et al.  Th9 Cells Represent a Unique Subset of CD4+ T Cells Endowed with the Ability to Eradicate Advanced Tumors. , 2024, Cancer cell.

[20]  M. Colombo,et al.  Cross-Talk between Myeloid-Derived Suppressor Cells and Mast Cells Mediates Tumor-Specific Immunosuppression in Prostate Cancer , 2018, Cancer Immunology Research.

[21]  W. Weninger,et al.  Imaging of mast cells , 2018, Immunological reviews.

[22]  L. Romani,et al.  The contribution of mast cells to bacterial and fungal infection immunity , 2018, Immunological reviews.

[23]  Xiaoming Shi,et al.  Guidance of super-enhancers in regulation of IL-9 induction and airway inflammation , 2018, The Journal of experimental medicine.

[24]  A. Pezeshki,et al.  Mast cells promote small bowel cancer in a tumor stage-specific and cytokine-dependent manner , 2018, Proceedings of the National Academy of Sciences.

[25]  Hayyoung Lee,et al.  Ectopically Expressed Membrane-bound Form of IL-9 Exerts Immune-stimulatory Effect on CT26 Colon Carcinoma Cells , 2018, Immune network.

[26]  R. Flavell,et al.  IRF8-dependent molecular complexes control the Th9 transcriptional program , 2017, Nature Communications.

[27]  M. Kaplan,et al.  Specifically differentiated T cell subset promotes tumor immunity over fatal immunity , 2017, The Journal of experimental medicine.

[28]  M. Verma,et al.  Experimental asthma persists in IL‐33 receptor knockout mice because of the emergence of thymic stromal lymphopoietin–driven IL‐9+ and IL‐13+ type 2 innate lymphoid cell subpopulations , 2017, The Journal of allergy and clinical immunology.

[29]  Tao Cui,et al.  Th9 cells promote antitumor immunity via IL‐9 and IL‐21 and demonstrate atypical cytokine expression in breast cancer , 2017, International immunopharmacology.

[30]  Maojie Yang,et al.  Foxo1 and Foxp1 play opposing roles in regulating the differentiation and antitumor activity of TH9 cells programmed by IL-7 , 2017, Science Signaling.

[31]  M. Neurath,et al.  Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cells , 2017, Nature Medicine.

[32]  Hai Qi,et al.  Germinal-center development of memory B cells driven by IL-9 from follicular helper T cells , 2017, Nature Immunology.

[33]  Yonghao Cao,et al.  Role of Mast Cells in the Pathogenesis of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis , 2017, Clinical Reviews in Allergy & Immunology.

[34]  Bang-li Hu,et al.  Interleukin-9 Promotes Pancreatic Cancer Cells Proliferation and Migration via the miR-200a/Beta-Catenin Axis , 2017, BioMed research international.

[35]  Hongwu Tan,et al.  A tumour‐promoting role of Th9 cells in hepatocellular carcinoma through CCL20 and STAT3 pathways , 2017, Clinical and experimental pharmacology & physiology.

[36]  D. He,et al.  Infiltrating mast cells promote renal cell carcinoma angiogenesis by modulating PI3K→AKT→GSK3β→AM signaling , 2017, Oncogene.

[37]  Liyuan Sun,et al.  Induction of specific T helper-9 cells to inhibit glioma cell growth , 2016, Oncotarget.

[38]  F. Végran,et al.  TH9 cells in anti-tumor immunity , 2016, Seminars in Immunopathology.

[39]  S. Fukushima,et al.  Peripheral blood Th9 cells are a possible pharmacodynamic biomarker of nivolumab treatment efficacy in metastatic melanoma patients , 2016, Oncoimmunology.

[40]  R. Häsler,et al.  Human Vδ2 T cells are a major source of interleukin-9 , 2016, Proceedings of the National Academy of Sciences.

[41]  I. Tillie‐Leblond,et al.  Mast cells are associated with exacerbations and eosinophilia in children with severe asthma , 2016, European Respiratory Journal.

[42]  J. Gariépy,et al.  Induction of antigen‐specific TH9 immunity accompanied by mast cell activation blocks tumor cell engraftment , 2016, International journal of cancer.

[43]  Siqing Wang,et al.  Dectin-1-activated dendritic cells trigger potent antitumour immunity through the induction of Th9 cells , 2016, Nature Communications.

[44]  B. Dréno,et al.  IL‐9 promotes the survival and function of human melanoma‐infiltrating CD4+CD8+ double‐positive T cells , 2016, European journal of immunology.

[45]  G. Vásquez,et al.  Th9 lymphocytes: A recent history from IL-9 to its potential role in rheumatic diseases. , 2016, Autoimmunity reviews.

[46]  Xin Wang,et al.  Interleukin-9 promotes cell survival and drug resistance in diffuse large B-cell lymphoma , 2016, Journal of experimental & clinical cancer research : CR.

[47]  L. Cerroni,et al.  STAT3/5-Dependent IL9 Overexpression Contributes to Neoplastic Cell Survival in Mycosis Fungoides , 2016, Clinical Cancer Research.

[48]  A. Barski,et al.  Induction of Interleukin-9-Producing Mucosal Mast Cells Promotes Susceptibility to IgE-Mediated Experimental Food Allergy. , 2015, Immunity.

[49]  H. Veiga-Fernandes,et al.  IL-9 Expression by Invariant NKT Cells Is Not Imprinted during Thymic Development , 2015, The Journal of Immunology.

[50]  Min Zhang,et al.  Inhibition of squamous cancer growth in a mouse model by Staphylococcal enterotoxin B-triggered Th9 cell expansion , 2015, Cellular and Molecular Immunology.

[51]  Kairong Cui,et al.  The DNA-binding inhibitor Id3 regulates IL-9 production in CD4+ T cells , 2015, Nature Immunology.

[52]  B. Kwon,et al.  Glucocorticoid-induced tumor necrosis factor receptor–related protein co-stimulation facilitates tumor regression by inducing IL-9–producing helper T cells , 2015, Nature Medicine.

[53]  M. Kaplan,et al.  TH9 cells are required for tissue mast cell accumulation during allergic inflammation. , 2015, The Journal of allergy and clinical immunology.

[54]  Yujiang Fang,et al.  IL‐9 inhibits HTB‐72 melanoma cell growth through upregulation of p21 and TRAIL , 2015, Journal of surgical oncology.

[55]  F. Végran,et al.  Th9 Cells: a Novel Cd4 T-cell Subset in the Immune War against Cancer the Role of Cd4 T-cell Polarization in Cancer the Biology of Th9 Cells the Mechanism of the Antitumor Effects of Th9 Future Direction and Concluding Remarks , 2022 .

[56]  S. Gendler,et al.  Inhibition of adaptive immunity by IL9 can be disrupted to achieve rapid T-cell sensitization and rejection of progressive tumor challenges. , 2014, Cancer research.

[57]  S. Quezada,et al.  An antitumor boost to TH9 cells , 2014, Nature Immunology.

[58]  Changyou Wu,et al.  Characteristics of γδ T cells in Schistosoma japonicum-infected mouse mesenteric lymph nodes , 2014, Parasitology Research.

[59]  B. Ryffel,et al.  The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells , 2014, Nature Immunology.

[60]  M. Huber,et al.  Heterogeneity in the Differentiation and Function of CD8+ T Cells , 2014, Archivum Immunologiae et Therapiae Experimentalis.

[61]  James E. Crooks,et al.  The intracellular B30.2 domain of butyrophilin 3A1 binds phosphoantigens to mediate activation of human Vγ9Vδ2 T cells. , 2014, Immunity.

[62]  Xin Wang,et al.  Overexpression of IL-9 induced by STAT6 activation promotes the pathogenesis of chronic lymphocytic leukemia. , 2014, International journal of clinical and experimental pathology.

[63]  E. Schmitt,et al.  Th9 cells, new players in adaptive immunity. , 2014, Trends in immunology.

[64]  Yuhuan Zheng,et al.  Tumor-specific IL-9–producing CD8+ Tc9 cells are superior effector than type-I cytotoxic Tc1 cells for adoptive immunotherapy of cancers , 2014, Proceedings of the National Academy of Sciences.

[65]  Xin Wang,et al.  Role of high expression of IL-9 in prognosis of CLL. , 2014, International journal of clinical and experimental pathology.

[66]  Chao Yang,et al.  Human TH9 Cells Are Skin-Tropic and Have Autocrine and Paracrine Proinflammatory Capacity , 2014, Science Translational Medicine.

[67]  Xin Wang,et al.  Role of IL-9 and STATs in hematological malignancies (Review) , 2013, Oncology letters.

[68]  R. Flavell,et al.  Th9 Cells Drive Host Immunity against Gastrointestinal Worm Infection. , 2013, Immunity.

[69]  Xin Wang,et al.  Overexpression of IL-9 receptor in diffuse large B-cell lymphoma. , 2013, International journal of clinical and experimental pathology.

[70]  Yong Lu,et al.  Utilizing TH9 cells as a novel therapeutic strategy for malignancies , 2013, Oncoimmunology.

[71]  M. Huber,et al.  Tc9 cells, a new subset of CD8+ T cells, support Th2‐mediated airway inflammation , 2013, European journal of immunology.

[72]  M. Kaplan.  Th9 cells: differentiation and disease , 2013, Immunological reviews.

[73]  E. Celis,et al.  Adoptive Transfer of Tc1 or Tc17 Cells Elicits Antitumor Immunity against Established Melanoma through Distinct Mechanisms , 2013, The Journal of Immunology.

[74]  P. Vantourout,et al.  Six-of-the-best: unique contributions of γδ T cells to immunology , 2013, Nature Reviews Immunology.

[75]  Mingli Yuan,et al.  Differentiation and immune regulation of IL-9-producing CD4+ T cells in malignant pleural effusion. , 2012, American journal of respiratory and critical care medicine.

[76]  Sungyoul Hong,et al.  Th9 cells promote antitumor immune responses in vivo. , 2012, The Journal of clinical investigation.

[77]  R. Clark,et al.  Robust tumor immunity to melanoma mediated by interleukin 9 , 2012, Nature Medicine.

[78]  Li-li Feng,et al.  IL-9 Contributes to Immunosuppression Mediated by Regulatory T Cells and Mast Cells in B-Cell Non-Hodgkin’s Lymphoma , 2011, Journal of Clinical Immunology.

[79]  Carsten Peterson,et al.  Molecular serum portraits in patients with primary breast cancer predict the development of distant metastases , 2011, Proceedings of the National Academy of Sciences.

[80]  G. Mayer,et al.  IL-9 Production by Regulatory T Cells Recruits Mast Cells That Are Essential for Regulatory T Cell-Induced Immune Suppression , 2011, The Journal of Immunology.

[81]  C. Morita,et al.  Cytokine Requirements for the Differentiation and Expansion of IL-17A– and IL-22–Producing Human Vγ2Vδ2 T Cells , 2010, The Journal of Immunology.

[82]  Qing Yu,et al.  The transcription factor PU.1 is required for the development of interleukin 9-producing T cells and allergic inflammation , 2010, Nature Immunology.

[83]  Qingsheng Li,et al.  Regulating functional cell fates in CD8 T cells , 2010, Immunologic research.

[84]  P. Muranski,et al.  Type 17 CD8+ T cells display enhanced antitumor immunity. , 2009, Blood.

[85]  J. Renauld,et al.  Acute Lymphoblastic Leukemia-associated JAK1 Mutants Activate the Janus Kinase/STAT Pathway via Interleukin-9 Receptor α Homodimers* , 2009, Journal of Biological Chemistry.

[86]  Christoph Wilhelm,et al.  Transforming growth factor-β 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9–producing subset , 2008, Nature Immunology.

[87]  V. Kuchroo,et al.  IL-4 inhibits TGF-β-induced Foxp3+ T cells and, together with TGF-β, generates IL-9+ IL-10+ Foxp3− effector T cells , 2008, Nature Immunology.

[88]  W. Leonard,et al.  IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy. , 2008, Blood.

[89]  T. Waldmann,et al.  Induction of the IL-9 gene by HTLV-I Tax stimulates the spontaneous proliferation of primary adult T-cell leukemia cells by a paracrine mechanism. , 2008, Blood.

[90]  Nikhil S. Joshi,et al.  Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. , 2007, Immunity.

[91]  H. Schild,et al.  Mast cells are crucial for early inflammation, migration of Langerhans cells, and CTL responses following topical application of TLR7 ligand in mice. , 2007, Blood.

[92]  D. Calame,et al.  Autocrine release of interleukin-9 promotes Jak3-dependent survival of ALK+ anaplastic large-cell lymphoma cells. , 2006, Blood.

[93]  M. Takahara,et al.  Expression of Interleukin-9 in Nasal Natural Killer/T-Cell Lymphoma Cell Lines and Patients , 2005, Clinical Cancer Research.

[94]  C. Chen,et al.  Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo. , 2005, The American journal of pathology.

[95]  B. Moser,et al.  Professional Antigen-Presentation Function by Human γδ T Cells , 2005, Science.

[96]  P. Hwu,et al.  Dendritic Cells Strongly Boost the Antitumor Activity of Adoptively Transferred T Cells In vivo , 2004, Cancer Research.

[97]  D. Kabelitz,et al.  Differentiation of Resting Human Peripheral Blood γδ T Cells toward Th1- or Th2-Phenotype , 2001 .

[98]  J. Marshall,et al.  Mast cells as targets for immunotherapy of solid tumors. , 2015, Molecular immunology.

[99]  Kristin J. Ness.  Cytokine requirements for the differentiation and expansion of IL-17a- and IL-22-producing human Vgamma2Vgamma2 T cells , 2011 .

[100]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..